1. Home
  2. WOLF vs GLUE Comparison

WOLF vs GLUE Comparison

Compare WOLF & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

N/A

Current Price

$24.87

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

N/A

Current Price

$9.35

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WOLF
GLUE
Founded
1987
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
WOLF
GLUE
Price
$24.87
$9.35
Analyst Decision
Hold
Strong Buy
Analyst Count
2
10
Target Price
$24.00
★ $25.38
AVG Volume (30 Days)
★ 2.9M
1.3M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $1,385,982,000.00
$123,672,000.00
Revenue This Year
$14.87
N/A
Revenue Next Year
$4.07
N/A
P/E Ratio
★ N/A
$72.42
Revenue Growth
19.00
★ 63.54
52 Week Low
$13.49
$9.31
52 Week High
$80.82
$25.77

Technical Indicators

Market Signals
Indicator
WOLF
GLUE
Relative Strength Index (RSI) 49.12 32.71
Support Level $23.31 N/A
Resistance Level $26.70 $12.00
Average True Range (ATR) 2.31 0.60
MACD 0.49 -0.05
Stochastic Oscillator 61.73 17.44

Price Performance

Historical Comparison
WOLF
GLUE

About WOLF Wolfspeed Inc.

Wolfspeed Inc is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Its product families include silicon carbide materials and power devices. Its products are targeted for various applications in the Automotive domain, including electric vehicles and fast charging, as well as existing and emerging applications in the Industrial & Energy domain such as AI data centers, grid modernization and renewable energy and storage as well as aerospace and defense. The company also use contract manufacturers, some of which include captive lines, for certain products and aspects of product fabrication, assembly and packaging. The company has one reportable segment. Majority of revenue comes from United States followed by Hong Kong.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Share on Social Networks: